Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Potent platelet aggregation inhibitors claimed by Meiji Seika

Dec. 1, 1999

YM-68128: orally active double prodrug of a potent antiplatelet agent

Dec. 1, 1999

Anticoagulant, antithrombotic compounds with heterocyclic structure

Nov. 30, 1999

Novel fibrinolytics recently patented by ADIR

Nov. 29, 1999

MonteGen offers potent antithrombotic agent for licensing

Nov. 29, 1999

Pharmacokinetics of EMD-132338 following oral administration of gantofiban

Nov. 25, 1999

FDA approves Aggrenox for prevention of recurrent stroke

Nov. 24, 1999

Anticoagulant serine protease inhibitors described by 3-D

Nov. 24, 1999

Preclinical data presented at AHA support promising profile of V-20

Nov. 17, 1999

Vapreotide superior to placebo in early treatment of portal hypertensive bleeding

Nov. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...